从质控到供应链：无血清培养试剂优势与细胞培养基血清替代物应用
从合规、动物源性风险控制与供应链可追溯角度，说明细胞培养基血清替代物如何放大无血清培养试剂优势，并给出选型要点。
细胞培养基血清替代物与无血清培养试剂优势解析
围绕细胞培养基血清替代物，分析无血清培养试剂在批次稳定性、成分可追溯和工艺放大中的优势，并给出研发质控建议。
Selection and Quality Control of Cell Culture Media in Biopharmaceutical Processes
Cell culture media are core raw materials in upstream biopharmaceutical processes. This article discusses their fundamen...
Key Materials and Quality Challenges in the Industrialization of CAR-T Cell Therapy
Focusing on the key points of quality control and supply chain management for critical materials such as viral vectors, ...
Analysis of Key Points in the Construction of Cell Culture Media Quality Control Systems and Compliance Management
The quality of cell culture media directly affects the safety of biologics and cell therapy products. This article start...
Trends in Serum-Free and Chemically Defined Media Development
Biopharmaceuticals and cell therapy are driving the development of serum-free and chemically defined media. This article...
Analysis of Common Classification of Cell Culture Media and Selection Principles for Laboratory and Production
The selection of cell culture media affects cell growth and process stability. This article reviews the characteristics ...
Cell Culture Media Quality Control and Supply Chain Compliance Essentials
Sort out the cell culture medium quality system, key indicators and supply chain management from the perspective of indu...
Cell Culture Media Types and Selection: From Basic Formulation to Serum-Free Optimization
Introduce the common classification of cell culture media, key components, and type selection ideas in process developme...